Literature DB >> 23472730

CT angiography in an acute stroke protocol: correlation between occlusion site and outcome of intravenous thrombolysis.

S Porelli1, M Leonardi, A Stafa, C Barbara, G Procaccianti, L Simonetti.   

Abstract

Thrombolysis with intravenous rt-PA is the current therapy for acute ischemic stroke. Unlike other outcome factors, relatively little is known about the prognostic value of the occlusion site on treatment outcome. We compared the effectiveness and safety of intravenous thrombolysis in patients with different levels of occlusion identified by CT angiography (CTA) in anterior circulation stroke, and analyzed the influence of the occlusion site on treatment outcome in relation to other outcome factors. We selected 71 patients from a stroke database collected between June 2007 and December 2011 at our hospital. All of the studied patients had anterior circulation stroke with intracranial occlusion detected by CTA and were treated with intravenous rt-PA. They were divided into two groups according to the site of occlusion along the middle cerebral artery course: proximal (carotid "T", complete M1 and mild M1 occlusions) and distal (M2/M3 occlusions). Treatment effectiveness was assessed by modified Rankin Scale (mRS) at three months, considering a positive outcome a mRS value ≤ 2. Treatment safety was assessed by evaluating the rate of hemorrhagic complications seen on unenhanced CT at 24 hours. Binary logistic regression was performed to evaluate the interaction between occlusion site and other variables such as sex, age, ASPECT score on admission and baseline NIHSS value in determining treatment outcome. The degree of effectiveness and safety differed when considering patients with proximal and distal occlusions. The percentage of successfully treated cases was 28.6% in the first group compared to 72% in the second, and the rate of hemorrhagic complications was 28.6% and 6% respectively. After adjustment for sex, age, ASPECT score on admission and baseline NIHSS value, occlusion site was the only variable significantly influencing treatment safety and, together with baseline NIHSS value, the only valid predictor of treatment effectiveness. We demonstrated a correlation between the site of arterial occlusion and outcome of intravenous thrombolysis. By helping the choice of the best therapeutic strategy depending on the identified occlusion site, CTA could be usefully added to the examinations included in the Stroke Protocol for the baseline evaluation of patients with suspected acute stroke.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23472730      PMCID: PMC3601625          DOI: 10.1177/159101991301900114

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  33 in total

Review 1.  Thrombolytic agents in the treatment of stroke.

Authors:  M S Pessin; G J Del Zoppo; C J Estol
Journal:  Clin Neuropharmacol       Date:  1990-08       Impact factor: 1.592

2.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

Authors:  E Mori; Y Yoneda; M Tabuchi; T Yoshida; S Ohkawa; Y Ohsumi; K Kitano; A Tsutsumi; A Yamadori
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.

Authors:  D Saňák; R Herzig; J Zapletalová; D Horák; M Král; D Skoloudík; A Bártková; T Veverka; M Heřman; P Kaňovský
Journal:  Acta Neurol Scand       Date:  2011-05       Impact factor: 3.209

5.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort.

Authors:  M Fiorelli; S Bastianello; R von Kummer; G J del Zoppo; V Larrue; E Lesaffre; A P Ringleb; S Lorenzano; C Manelfe; L Bozzao
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

6.  Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.

Authors:  J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

Authors:  C Berger; M Fiorelli; T Steiner; W R Schäbitz; L Bozzao; E Bluhmki; W Hacke; R von Kummer
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

8.  Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.

Authors:  Laurent Derex; Norbert Nighoghossian; Marc Hermier; Patrice Adeleine; Yves Berthezène; Frédéric Philippeau; Jérôme Honnorat; Jean-Claude Froment; Paul Trouillas
Journal:  J Neurol Sci       Date:  2004-10-15       Impact factor: 3.181

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.

Authors:  Italo Linfante; Rafael H Llinas; Magdy Selim; Claudia Chaves; Sandeep Kumar; Robert A Parker; Louis R Caplan; Gottfried Schlaug
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  6 in total

1.  Bridging Therapy with i. v. rtPA in MCA Occlusion Prior to Endovascular Thrombectomy: a Double-Edged Sword?

Authors:  Johannes Kaesmacher; Justus F Kleine
Journal:  Clin Neuroradiol       Date:  2016-08-19       Impact factor: 3.649

2.  Mechanical embolectomy for acute ischemic stroke in the anterior cerebral circulation: the Gothenburg experience during 2000-2011.

Authors:  A Rentzos; C Lundqvist; J-E Karlsson; V Vilmarsson; K Schnabel; G Wikholm
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-19       Impact factor: 3.825

3.  Association of Cortical Vein Filling with Clot Location and Clinical Outcomes in Acute Ischaemic Stroke Patients.

Authors:  Sonu Bhaskar; Andrew Bivard; Peter Stanwell; John R Attia; Mark Parsons; Michael Nilsson; Christopher Levi
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

4.  Computed tomography perfusion and computed tomography angiography for prediction of clinical outcomes in ischemic stroke patients after thrombolysis.

Authors:  Jia-Wei Pan; Xiang-Rong Yu; Shu-Yi Zhou; Jian-Hong Wang; Jun Zhang; Dao-Ying Geng; Tian-Yu Zhang; Xin Cheng; Yi-Feng Ling; Qiang Dong
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

5.  Staged Endovascular Treatment for Symptomatic Occlusion Originating From the Intracranial Vertebral Arteries in the Early Non-acute Stage.

Authors:  Hongzhou Duan; Li Chen; Shengli Shen; Yang Zhang; Chunwei Li; Zhiqiang Yi; Yingjin Wang; Jiayong Zhang; Liang Li
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

6.  Stent Retriever Thrombectomy of Small Caliber Intracranial Vessels Using pREset LITE: Safety and Efficacy.

Authors:  W Kurre; M Aguilar-Pérez; R Martinez-Moreno; E Schmid; H Bäzner; H Henkes
Journal:  Clin Neuroradiol       Date:  2016-01-21       Impact factor: 3.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.